undefined

Neil Shah

Academic hematologist at the University of California, San Francisco with expertise in individualized treatment of chronic phase CML and long experience with tyrosine kinase inhibitors.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app